FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Yankie Lisa 2. Issuer Name and Ticker or Trading Symbol DENTSPLY SIRONA Inc. [ XRAY ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Sr VP & Chief HR Officer
(Last)         (First)         (Middle)
13320 BALLANTYNE CORPORATE PLACE
3. Date of Earliest Transaction (MM/DD/YYYY)
11/11/2019
(Street)
CHARLOTTE, NC 28277
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  11/11/2019    A(1)    4430  A $0  4430  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)  $55.70  11/11/2019    A     3700      11/11/2020 (2) 11/11/2029  Common Stock  3700  $0  3700  D   

Explanation of Responses:
(1)  Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending November 11, 2022.
(2)  Stock Options vest in annual one-third (1/3) increments over a three-year period ending November 11, 2022.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Yankie Lisa
13320 BALLANTYNE CORPORATE PLACE
CHARLOTTE, NC 28277


Sr VP & Chief HR Officer

Signatures
Dane Baumgardner, Attorney-In-Fact for Lisa Yankie 11/13/2019
**Signature of Reporting Person Date
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Sep 2020 to Oct 2020 Click Here for more DENTSPLY SIRONA Charts.
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Oct 2019 to Oct 2020 Click Here for more DENTSPLY SIRONA Charts.